miRNA regulation of T cell exhaustion in cutaneous T cell lymphoma [CTCL_antimir]
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
Cobomarsen (MRG‐106), an oligonucleotide inhibitor of miR‐155, has been evaluated in a clinical phase 1/2 trial for CTCL. We used lesional skin samples from 6 CTCL patients to identify the critical pathways affected by miR‐155 inhibition in CTCL. 6 CTCL patients (baseline and after 4 weeks of treatment with cobomarsen to identify the critical pathways affected by miR‐155 inhibition in CTCL.
创建时间：
2021-12-07
